Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Asikainen S. |
Small RNA-mediated Gene Regulation in Caenorhabditis elegans.
|
|
2 |
Carlberg C, Seuter S. |
A genomic perspective on vitamin D signaling.
|
|
3 |
Degenhardt T. |
An Integrated View of PPAR-Dependent Transcription.
|
|
4 |
Degenhardt T et al. |
Population-level transcription cycles derive from stochastic timing of single-cell transcription.
|
|
5 |
Degenhardt T et al. |
Peroxisome proliferator-activated receptor [alpha] controls hepatic heme biosynthesis throught ALAS1.
|
|
6 |
Eisold M et al. |
Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
|
|
7 |
Hennetin J et al. |
Construction and use of gene expression covariation matrix.
|
|
8 |
Häyrinen J et al. |
Proteomic analysis reveals altered energy metabolism in a transgenic mouse line with activated polyamine catabolism.
|
|
9 |
Kiviranta PH et al. |
N(epsilon)-Thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.
|
|
10 |
Laverny G. |
Identification of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease.
|
|
11 |
Lehtivarjo J et al. |
4D prediction of protein 1H chemical shifts.
|
|
12 |
Makkonen KM et al. |
Cell cycle regulatory effects of retinoid acid and forskolin are mediated by the Cyclin C gene.
|
|
13 |
Makkonen KM et al. |
Regulation of the hyaluronan synthase 2 gene by convergence in cyclic AMP response element-binding protein and retinoid acid receptor signaling.
|
|
14 |
Malinen M. |
Transactivation of Vitamin D Receptor Target Genes by Natural and Synthetic Ligands.
|
|
15 |
Paananen J, Wong G. |
FORG3D: Force-directed 3D graph editor for visuallization of integrated genome scale data.
|
|
16 |
Peräkylä M. |
Ligand unbinding pathways from the vitamin D receptor studied by molecular dynamics simulations.
|
|
17 |
Piltti J et al. |
Proteomics of chondrocytes with special reference to phosphorylation changes of proteins in steched human chondrosarcoma cells.
|
|
18 |
Pulkkinen J et al., inventor. |
Novel beta-hydroxyketones and beta-alkoxyketones with estrogenic activity.
|
|
19 |
Pulkkinen J et al., inventor. |
Novel 4,5-dihydroisoxazoles with estrogenic activity.
|
|
20 |
Rytinki MM et al. |
PIAS proteins: pleiotropic interactors associated with SUMO.
|
|
21 |
Saramäki A et al. |
Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1[alpha],25-dihydroxyvitamin D3.
|
|
22 |
Turunen MP et al. |
Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy.
|
|
23 |
Törönen P et al. |
Generation of gene ontology benchmark datasets with various types of positive signal.
|